Abstract
The decreased incidence of allergic manifestations in cancer patients compared with noncancer patients is accompanied by a reduced skin sensitivity to histamine.1 Another potent mediator of inflammatory and allergic responses is PAF-acether.:' 3 Previous studies have demonstrated that intradermal injections of PAFacether induced wheal-and-flare response. 4, 5 Therefore, we studied skin response to PAF-acether in cancer patients (Table I). All the components of the skin response to histamine and PAF-acether were depressed in our cancer patients. A decreased flare response to PAF-acether
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
